
Danaher Corporation
DHR
Updated: 24/09/2026, 18:58:10
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
No summaries found.
The original document can be viewed now. Detailed facts and exposure relationships will appear after the separate extraction job completes.
- Share price
- $220.94
- Market cap
- $155.21B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Rainer Blair
- Employees
- 59,000
- IPO date
- 29/12/1978
- Beta
- 0.8080000000000001
- Last dividend
- $0.00
- Day range
- $219.00 – $226.64
- 52-week range
- $160.93 – $242.80
- 1-day performance
- -0.28%
- 1-year performance
- 37.29%
- Current drawdown (1Y)
- -9.00%
- CIK
- 0000313616
- CUSIP
- 235851102
- ISIN
- US2358511028
- Created
- 07/12/2025, 03:35:55
- Last update
- 24/09/2026, 18:58:10
Track Danaher Corporation with an AI analyst
See which prediction-market events move DHR, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Danaher Boosts Product Portfolio With the Acquisition of Masimo
Zacks Investment Research • STOCK • 12/06/2026, 13:06:12
Implied Volatility Surging for Danaher Stock Options
Zacks Investment Research • STOCK • 12/06/2026, 11:26:08
Strong Performance Continues at DHR's Biotechnology Unit: What's Next?
Zacks Investment Research • STOCK • 11/06/2026, 14:16:43
Why Is Danaher (DHR) Down 7% Since Last Earnings Report?
Zacks Investment Research • STOCK • 21/05/2026, 14:31:28
Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead?
Zacks Investment Research • STOCK • 20/05/2026, 14:21:07
Danaher Corporation (DHR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Seeking Alpha • STOCK • 13/05/2026, 19:10:43
Danaher Q1 2026 Earnings Update
Seeking Alpha • STOCK • 22/04/2026, 16:30:00
Danaher (NYSE: DHR) Q1 2026 Earnings: Mixed Results Amidst Strong Segment Growth and Strategic Acquisitions
Market Data • Market Data • 21/04/2026, 22:16:13
Danaher Posts Q1 Earnings Beat But Misses Revenue Expectations
Market Data • Market Data • 21/04/2026, 15:56:06
Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Up Y/Y
Zacks Investment Research • STOCK • 21/04/2026, 15:31:12
LH or DHR: Which Is the Better Value Stock Right Now?
Zacks Investment Research • STOCK • 21/04/2026, 14:42:16
Danaher Corporation (DHR) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 21/04/2026, 13:20:58